Form 8-K - Current report:
SEC Accession No. 0000950170-25-100891
Filing Date
2025-07-31
Accepted
2025-07-31 16:07:20
Documents
12
Period of Report
2025-07-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opk-20250731.htm   iXBRL 8-K 49590
2 EX-99.1 opk-ex99_1.htm EX-99.1 267538
3 GRAPHIC img172623995_0.jpg GRAPHIC 12371
  Complete submission text file 0000950170-25-100891.txt   452521

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT opk-20250731.xsd EX-101.SCH 23846
14 EXTRACTED XBRL INSTANCE DOCUMENT opk-20250731_htm.xml XML 4484
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)